We next established cell lines from four to five independent MT/ShcA+/+, MT/Shc2F/2F and MT/Shc313F/313F mammary tumours to test whether ShcA signalling in the epithelial compartment contributes to immune suppression. This evidence concerns the gene SHC1 and breast cancer.